
Stock Movers: Novartis, Soitec, Nordex (Podcast)
Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Novartis shares fall as much as 3.9% after the Swiss pharma group’s potential blockbuster heart drug, pelacarsen, failed in a final-stage study. It’s the company’s second trial disappointment within a week, coming days after Novartis temporarily paused trials of an experimental cell therapy for autoimmune diseases.
- Nordex shares rise as much as 8.8%, the most in over four months, after being upgraded to buy at BofA Global Research. Analysts said they see “significant&rdquo…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.